发明名称 |
Long lasting drug formulations |
摘要 |
<p>The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin.</p> |
申请公布号 |
AU2011268458(B2) |
申请公布日期 |
2014.06.12 |
申请号 |
AU20110268458 |
申请日期 |
2011.06.15 |
申请人 |
MEDGENICS MEDICAL ISRAEL LTD. |
发明人 |
PEARLMAN, ANDREW L.;STERN, BARUCH S. |
分类号 |
A61K48/00;C07H21/04;C12N5/00;C12N15/00 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|